Form 8-K - Current report:
SEC Accession No. 0001193125-25-116940
Filing Date
2025-05-09
Accepted
2025-05-09 16:51:27
Documents
13
Period of Report
2025-05-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d883656d8k.htm   iXBRL 8-K 24787
  Complete submission text file 0001193125-25-116940.txt   150775

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20250507.xsd EX-101.SCH 2531
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20250507_lab.xml EX-101.LAB 19225
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20250507_pre.xml EX-101.PRE 11696
16 EXTRACTED XBRL INSTANCE DOCUMENT d883656d8k_htm.xml XML 3937
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 25931307
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)